AU Stock MarketDetailed Quotes

NAN Nanosonics Ltd

Watchlist
  • 3.010
  • -0.070-2.27%
20min DelayMarket Closed Dec 27 16:00 AET
913.68MMarket Cap71.67P/E (Static)

About Nanosonics Ltd Company

Nanosonics is a single-product firm and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics’ revenue is made up of capital sales of Trophon units, ongoing consumables sales, and service revenue. By June 2022, there were 29,850 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, about 44% in the US to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.

Company Profile

SymbolNAN
Company NameNanosonics Ltd
Founded2000
MarketASX
Employees466
Fiscal Year Ends06-30
Address7-11 Talavera Road Level 1 Building A
CitySydney
CountryAustralia
Zip Code2113
Phone+61 280631600
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED Level 17, 221 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000 1300 850 505

Company Executives

  • Name
  • Position
  • Salary
  • Michael Kavanagh
  • Director, President, Managing Director and Chief Executive Officer
  • --
  • Steven Sargent
  • Chairman of the Board
  • --
  • Marie McDonald
  • Independent Director
  • --
  • Dr. Tracey Batten, M.B.A.,M.B.B.S.,M.H.A
  • Independent Director
  • --
  • Larry Marshall
  • Independent Director
  • --
  • Geoff Wilson
  • Independent Director
  • --
  • David Fisher
  • Independent Director
  • --
  • Dr. Lisa M. McIntyre
  • Independent Director
  • --